Adjuvants are not just a tool for vaccine developers. They offer a crucial response to an immune system’s failure to adequately react when dosed with vaccine. They have become an integral part of the solution for fighting disease and increasing capacity.
Adjuvants and other novel Delivery Systems have gained greater appreciation as a key to creating the next generation of vaccines. They boost vaccines’ potency while also cutting costs by decreasing dosage requirements. Advances also make it possible to distribute vaccines in developing countries that lie beyond the 'cold chain,' and promise greater efficacy using smaller amounts.
Lack of FDA approval for new adjuvants presents a major hurdle for vaccine developers, as do the pressing concerns for undesirable side effects. But these barriers cannot block the overwhelming tide of innovation that is forcing regulatory agencies to expand guidelines and revise review processes.
In the Novel Vaccines: Adjuvants & Delivery Systems meeting, vaccine leaders will discuss their promising work that is leading the way to a new era of safe and efficacious vaccines.
Conference Sessions:
Topics Include:
If you would like to give an oral presentation at this conference, please submit a proposal including a title and brief summary about your recent work in the area of Adjuvants and Delivery Systems for Vaccines.
All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference.
If you are interested in presenting, please click here to submit a speaking proposal for review.
Deadline for submission is February 12, 2010
For more details on the conference, please contact:
Mary Ruberry
Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5421
Email: mruberry@healthtech.com
For partnering and sponsorship information, please contact:
Suzanne Carroll
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Email: scarroll@healthtech.com